Atlas Trials

Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules

Clinical trial NCT07087080 · RECRUITING

Trial details

NCT number
NCT07087080
Sponsor
Hasselt University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Solitary Pulmonary NodulesLung Cancer
Start date
2022-03-02
Primary completion
2027-04-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.